Pros and cons of GLP-1 agonists and DPP-IV inhibitors

被引：0
|
作者：
Toft, Anders Dyhr [1 ]
机构：
[1] Novo Nordisk AS, Virum, Denmark
来源：
IDRUGS | 2007年 / 10卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：606 / 609
页数：4
相关论文
共 50 条
  • [21] Impact of Either GLP-1 Agonists or DPP-4 Inhibitors on Pathophysiology of Heart Failure
    Takahashi, Ayako
    Ihara, Madoka
    Yamazaki, Satoru
    Asanuma, Hiroshi
    Asakura, MaSarlori
    Kitakaze, Masafumi
    INTERNATIONAL HEART JOURNAL, 2015, 56 (04) : 372 - 376
  • [22] Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors
    Bistola, Vasiliki
    Lambadiari, Vaia
    Dimitriadis, George
    Ioannidis, Ioannis
    Makrilakis, Konstantinos
    Tentolouris, Nikolaos
    Tsapas, Apostolos
    Parissis, John
    HEART FAILURE REVIEWS, 2018, 23 (03) : 377 - 388
  • [23] GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
    Ahrén, B
    Schmitz, O
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 867 - 876
  • [24] Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
    Brown, Dominique Xavier
    Evans, Marc
    JOURNAL OF NUTRITION AND METABOLISM, 2012, 2012
  • [25] Discovery of potent DPP-IV inhibitors
    Chen, YX
    Richards, S
    Shuai, Q
    Patel, J
    Madar, D
    Yong, H
    Pei, ZH
    von Geldern, TW
    Longenecker, KL
    Stewart, K
    Lubben, T
    Ballaron, S
    Stashko, M
    Trevillyan, J
    Sham, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2675 - U2675
  • [26] Inhibition of DPP-IV Activity and Stimulation of GLP-1 Release by Gastrointestinally Digested Black Soldier Fly Prepupae
    Valentina Luparelli, Anna
    Miguens-Gomez, Alba
    Ardevol, Anna
    Sforza, Stefano
    Caligiani, Augusta
    Pinent, Montserrat
    FOODS, 2023, 12 (10)
  • [27] Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects
    Dai, Haiqinq
    Gustavson, Stephanie M.
    Preston, Gregory M.
    Eskra, James D.
    Calle, Roberto
    Hirshberg, Boaz
    DIABETES OBESITY & METABOLISM, 2008, 10 (06): : 506 - 513
  • [28] A Local GLP-1 System In Human Pancreatic Islets: The Role Of DPP-IV Inhibition by MK-0626
    Bugliani, Marco
    Syed, Farooq
    Suleiman, Mara
    Olimpico, Francesco
    Boggi, Ugo
    Kirkpatrick, Clare
    Wollheim, Claes
    Masini, Matilde
    Masiello, Pellegrino
    Filipponi, Franco
    Marselli, Lorella
    Marchetti, Piero
    DIABETES, 2013, 62 : A96 - A96
  • [29] The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
    Secrest, Matthew H.
    Udell, Jacob A.
    Filion, Kristian B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (03) : 194 - 202
  • [30] Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Payk, Stephanie L.
    Drew, Richard H.
    Smith, Jennifer D.
    Jiroutek, Michael R.
    Holland, Melissa A.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1477 - 1482
12345